Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/29/16  and contains information from public web pages and contributions from the ZoomInfo community.

Deputy Managing Editor

Phone: (304) ***-****  
Email: j***@***.com
Local Address:  Maryland , United States
MedPage Today LLC
150 Clove Road 10Th Floor
Little Falls , New Jersey 07424
United States

Company Description: MedPage Today's mission is to be the leading provider of real-time 24/7 breaking medical news coverage for healthcare professionals.

Employment History


  • M.S.
    Boston University
  • B.S.
    University of Michigan
190 Total References
Web References
tysabri, 3 June 2008 [cached]
By John Gever, Staff Writer, MedPage Today SAN DIEGO, May 18 -- Patients treated with natalizumab Tysabri for multiple sclerosis or Crohn&39s disease since ...
By John Gever, Senior ..., 25 July 2015 [cached]
By John Gever, Senior Editor, MedPage Today The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to US patients. According to the FDA, ...See all stories... ...
Management Team, 4 Aug 2015 [cached]
John Gever, Managing Editor John Gever has covered biomedicine and medical technology for nearly 30 years. He holds a B.S. from the University of Michigan and an M.S. from Boston University. A New York native now based in Wheeling, W.Va., his career has also taken him to Massachusetts, New Hampshire, New Jersey, Alabama, and Oregon. He has written for a wide variety of publications covering the biotechnology, pharmaceutical, and in vitro diagnostics field, as well as for magazines and daily and weekly newspapers., 28 May 2014 [cached]
HypeWatch: 'Significantly' More Orgasms? Published: May 28, 2014 By John Gever, Deputy Managing ...
Published: May 28, 2014 By John Gever, Deputy Managing Editor, MedPage Today | A A Here's a textbook example of a clinical trial result that is statistically significant but, in clinical terms, most likely meaningless.
This post comes from John Gever.
HypeWatch: 'Significantly' More Orgasms?
Published: May 28, 2014
By John Gever, Deputy Managing Editor, MedPage Today
This post comes from John Gever.
Health News 08/2012 (Page 6), 26 Aug 2012 [cached]
By John Gever, Senior Editor, MedPage Today SILVER SPRING, Md. -- The FDA has approved ranibizumab (Lucentis) for treatment of diabetic macular edema (DME), the agency said Friday.
Other People with the name "Gever":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.